12:00 AM
Jan 03, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Cognision System: Pivotal trial started

Neuronetrix began a pivotal U.S. trial to evaluate its Cognision System in about 240 patients with early AD and healthy controls.

Neuronetrix Inc., Louisville,...

Read the full 105 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >